These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 26859132)
1. Cell therapy for retinal disease. Ehmann D; Shahlaee A; Ho AC Curr Opin Ophthalmol; 2016 May; 27(3):185-90. PubMed ID: 26859132 [TBL] [Abstract][Full Text] [Related]
2. Stem cell therapy for retinal disease. Tibbetts MD; Samuel MA; Chang TS; Ho AC Curr Opin Ophthalmol; 2012 May; 23(3):226-34. PubMed ID: 22450217 [TBL] [Abstract][Full Text] [Related]
3. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics. Hinkle JW; Mahmoudzadeh R; Kuriyan AE Stem Cell Res Ther; 2021 Oct; 12(1):538. PubMed ID: 34635174 [TBL] [Abstract][Full Text] [Related]
4. Stem Cells for Retinal Disease: A Perspective on the Promise and Perils. Rao RC; Dedania VS; Johnson MW Am J Ophthalmol; 2017 Jul; 179():32-38. PubMed ID: 28428049 [TBL] [Abstract][Full Text] [Related]
5. Pluripotent human stem cells for the treatment of retinal disease. Rowland TJ; Buchholz DE; Clegg DO J Cell Physiol; 2012 Feb; 227(2):457-66. PubMed ID: 21520078 [TBL] [Abstract][Full Text] [Related]
7. Stem cells in clinical trials for treatment of retinal degeneration. Klassen H Expert Opin Biol Ther; 2016; 16(1):7-14. PubMed ID: 26414165 [TBL] [Abstract][Full Text] [Related]
8. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Schwartz SD; Regillo CD; Lam BL; Eliott D; Rosenfeld PJ; Gregori NZ; Hubschman JP; Davis JL; Heilwell G; Spirn M; Maguire J; Gay R; Bateman J; Ostrick RM; Morris D; Vincent M; Anglade E; Del Priore LV; Lanza R Lancet; 2015 Feb; 385(9967):509-16. PubMed ID: 25458728 [TBL] [Abstract][Full Text] [Related]
9. Eyes open to stem cells: safety trial may pave the way for cell therapy to treat retinal disease in patients. Medina RJ; Archer DB; Stitt AW Stem Cell Res Ther; 2011 Dec; 2(6):47. PubMed ID: 22152341 [TBL] [Abstract][Full Text] [Related]
10. Update on ocular gene therapy and advances in treatment of inherited retinal diseases and exudative macular degeneration. Garoon RB; Stout JT Curr Opin Ophthalmol; 2016 May; 27(3):268-73. PubMed ID: 26918787 [TBL] [Abstract][Full Text] [Related]
11. Ocular Stem Cell Research from Basic Science to Clinical Application: A Report from Zhongshan Ophthalmic Center Ocular Stem Cell Symposium. Ouyang H; Goldberg JL; Chen S; Li W; Xu GT; Li W; Zhang K; Nussenblatt RB; Liu Y; Xie T; Chan CC; Zack DJ Int J Mol Sci; 2016 Mar; 17(3):415. PubMed ID: 27102165 [TBL] [Abstract][Full Text] [Related]
12. Cell-based therapies for retinal degenerative diseases: a thousand strategies. Lewallen M; Xie T J Glaucoma; 2013; 22 Suppl 5():S42-5. PubMed ID: 23733127 [TBL] [Abstract][Full Text] [Related]
13. Gene therapy and animal models for retinal disease. Dejneka NS; Rex TS; Bennett J Dev Ophthalmol; 2003; 37():188-98. PubMed ID: 12876838 [TBL] [Abstract][Full Text] [Related]
15. Stem Cell-Based Therapy for Diseases of the Retinal Pigment Epithelium: From Bench to Bedside. Sachdeva MM; Eliott D Semin Ophthalmol; 2016; 31(1-2):25-9. PubMed ID: 26959126 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Park SS; Bauer G; Abedi M; Pontow S; Panorgias A; Jonnal R; Zawadzki RJ; Werner JS; Nolta J Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):81-9. PubMed ID: 25491299 [TBL] [Abstract][Full Text] [Related]
17. Stem cell therapies for retinal diseases: from bench to bedside. Shen Y J Mol Med (Berl); 2020 Oct; 98(10):1347-1368. PubMed ID: 32794020 [TBL] [Abstract][Full Text] [Related]
18. Stargardt's disease and the ABCR gene. Westerfeld C; Mukai S Semin Ophthalmol; 2008; 23(1):59-65. PubMed ID: 18214793 [TBL] [Abstract][Full Text] [Related]